Cipla Limited -0.2 % Drug Manufacturers - Major

Trend Analysis


Support and Resistance Levels Analysis
The current close value 512.6 is between the support and resistance channel of 503 and 544. The stock has a Observe Signal , 503 becomes a critical support to stop the fall and 544 is a immediate resistance on the upside. Note that in case of a Observe Signal, the stocks tends to change trends. This happens mostly near the support and resistance levels.
Technical Indicators (3 Month duration)
Exponential Moving average 519.3
MACD value -20.0
Price range 512.55 to 672.80
Volume range 1532265 to 7187274
Support & Resistance 503, 544
Stock Performance
Six Months -16.2%
Five Months-19.2%
Four Months-20.4%
Three Months-22.9%
Two Months-20.9%
One Month-3.6%
Last Six Months


Last Five Months


Last Four Months


Last Three Months


Last Two Months


Last One Month


Today's Price Range
3 Month Price Range
About Cipla Limited
Cipla Limited (Cipla) is an India-based global pharmaceutical company. The Company's portfolio includes approximately 2000 products in 65 therapeutic categories with one quality standard globally. Cipla's turnover in 2012/13 was approximately 1.5 billion USD. The Company's research and development focus on developing products and drug delivery systems for different formulations. Africa contributes 25% of overall revenues, a testament to its focus on ensuring affordable access to patients across the world. As the Company that showed the way in manufacturing active pharmaceutical ingredients in India, Cipla has expanded its portfolio to approximately 200 products. The Company offers approximately 65 different inhaled products and has a range of inhaled medications and devices. Across markets, Cipla offers metered dose inhalers (pMDIs) with dose indicators, innovative dry powder inhalers, nasal sprays, nebulisers, non-electrostatic spacers, and infant and baby masks.
See stocks similar to Cipla Limited in Drug Manufacturers - Major

Cipla Limited has Observe Signal. What is your opinion on it?

{ }